Overview of Pathogenesis

Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Seventh Edition

Volumn , Issue , 2009, Pages 203-206

  Raisz, Lawrence G ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78149408979     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470623992.ch39     Document Type: Chapter

References (61)

1. Raisz LG 2005 Pathogenesis of osteoporosis: Concepts, conflicts, and prospects. J Clin Invest 115:3318-3325.
2. NIH 2001 Consensus Conference: Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785-795.
3. Bollerslev J, Wilson SG, Dick IM, Islam FM, Ueland T, Palmer L, Devine A, Prince RL 2005 LRP5 gene polymorphisms predict bone mass and incident fractures in elderly Australian women. Bone 36:599-606.
4. Loannidis JP, Ralston SH, Bennett ST, Brandi ML, Grinberg D, Karassa FB. Langdahl B, van Meurs JB, Mosekilde L, Scollen S, Albagha OM, Bustamante M, Carey AH, Dunning AM, Enjuanes A, van Leeuwen JP. Mavilia C, Masi L, McGuigan FE, Nogues X, Pols HA, Reid DM, Schuit SC, Sherlock RE, Uitterlinden AG 2004 Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. JAMA 292:2105-2114.
5. Balemans W, Ebeling M, Patel N, Van Hul E, Olson P, Dioszegi M, Lacza C, Wuyts W, Van Den Ende J, Willems P, Paes-Alves AF, Hill S, Bueno M, Ramos FJ, Tacconi P. Dückers FG, Stratakis C, Lindpaintner K, Vickery B, Foernzler D, Van Hul W 2001 Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SÖST). Hum Mol Genet 10:537-543.
6. Little RD, Carulli JP, Del Mastro RG, Dupuis J, Osborne M, Folz C, Manning SP, Swain PM, Zhao SC, Eustace B, Lappe MM, Spitzer L, Zweier S, Braunschweiger K, Benchekroun Y, Hu X, Adair R, Chee L, FitzGerald MG, Tulig C, Caruso A, Tzellas N, Bawa A, Franklin B, McGuire S, Nogues X, Gong G, Allen KM, Anisowicz A, Morales AJ, Lomedico PT, Recker SM, Van Eerde-wegh P, Recker RR, Johnson ML 2002 A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 70:11-19.
7. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S. Regi-nato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins WN, Allgrove J, Arslan-Kirchner M, Batch JA, Beighton P, Black GC, Boles RG, Boon LM, Borrone C, Brunner HG, Carle GF, Dallapiccola B, De Paepe A, Floege B, Halfhide ML, Hall B, Hennekam RC, Hirose T, Jans A, Juppner H, Kim CA, Keppler-Noreuil K, Kohlschuetter A, LaCombe D, Lambert M, Lemyre E, Letteboer T, Peltonen L, Ramesar RS, Romanengo M, Somer H, Steichen-Gersdorf E, Steinmann B, Sullivan B, Superti-Furga A, Swoboda W, van den Boogaard MJ, Van Hul W, Vikkula M, Votruba M, Zabel B, Garcia T, Baron R, Olsen BR, Warman ML 2001 LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107:513-523.
8. Hartikka H, Makitie O, Mannikko M, Doria AS, Daneman A, Cole WG, Ala-Kokko L, Sochett EB 2005 Heterozygous mutations in the LDL receptor-related protein 5 (LRP5) gene are associated with primary osteoporosis in children. J Bone Miner Res 20:783-789.
9. Ralston SH 2007 Genetics of osteoporosis. Proc Nutr Soc 66:158-165.
10. McLean RR, Jacques PF, Seihub J, Tucker KL, Samelson EJ, Broe KE, Hannan MT, Cupples LA, Kiel DP 2004 Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 350:2042-2049.
11. Perier MA, Gineyts E, Munoz F, Sornay-Rendu E, Delmas PD 2007 Homocysteine and fracture risk in postmenopausal women: The OFELY study. Osteoporos Int 18:1329-1336.
12. van Meurs JB, Dhonukshe-Rutten RA. Pluijm SM, van der Klift M, de Jonge R, Lindemans J, de Groot LC, Hofman A. Witteman JC, van Leeuwen JP, Breteler MM, Lips P, Pols HA, Uitterlinden AG 2004 Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 350:2033-2041.
13. Herrmann M, Widmann T, Herrmann W 2006 Re:"Elevated serum homocysteine and McKusick's hypothesis of a disturbed collagen cross-linking:What do we really know?" Bone 39:1385-1286.
14. Saito M, Fujii K, Soshi S, Tanaka T 2006 Reductions in degree of mineralization and enzymatic collagen cross-links and increases in glycation-induced pentosidine in the femoral neck cortex in cases of femoral neck fracture. Osteoporos Int 17:986-995.
15. Tang SY, Zeenath U, Vashishth D 2007 Effects of non-enzymatic glycation on cancellous bone fragility. Bone 40:1144-1151.
16. Lock CA, Lecouturier J, Mason JM, Dickinson HO 2006 Lifestyle interventions to prevent osteoporotic fractures: A systematic review. Osteoporos Int 17:20-28.
17. Lips P 2001 Vitamin D deficiency and secondary hyperparathyroidism in the elderly: Consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22:477-501.
18. Kaneki M, Hosoi T, Ouchi Y, Orimo H 2006 Pleiotropic actions of vitamin K: Protector of bone health and beyond? Nutrition 22:845-852.
19. Baines M, Kredan MB, Usher J, Davison A, Higgins G, Taylor W, West C, Fraser WD, Ranganath LR 2007 The association of homocysteine and its determinants MTHFR genotype, folate, vitamin B12 and vitamin B6 with bone mineral density in postmenopausal British women. Bone 40:730-736.
20. Ferrari S, Manen D, Bonjour JP, Slosman D, Rizzoli R 1999 Bone mineral mass and calcium and phosphate metabolism in young men: Relationships with vitamin D receptor allelic polymorphisms. J Clin Endocrinol Metab 84:2043-2048.
21. Chevalley T, Bonjour JP, Ferrari S, Rizzoli R 2008 High protein intake enhances the postive impact of physical activity on bone mineral content in pre-pubertal boys. J Bone Miner Res 23:131-142.
22. Wong PK, Christie JJ, Wark JD 2007 The effects of smoking on bone health. Clin Sci (Lond) 113:233-241.
23. Khosla S, Riggs BL, Atkinson EJ, Oberg AL, McDaniel U, Holets M, Peterson JM, Melton LJ III 2006 Effects of sex and age on bone microstructure at the ultradistal radius: A population-based noninvasive in vivo assessment. J Bone Miner Res 21:124-131.
24. Falahati-Nini A, Riggs BL, Atkinson EJ, O'Fallon WM, Eastell R, Khosla S 2000 Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest 106:1553-1560.
25. Taxel P, Kaneko H, Lee SK, Aguila HL, Raisz LG, Lorenzo JA 2008 Estradiol rapidly inhibits osteoclastogenesis and RANKL expression in bone marrow cultures in postmenopausal women: A pilot study. Osteoporos Int 19:193-199.
26. Pacifici R 2007 Estrogen deficiency, T cells and bone loss. Cell Immunol (in press).
27. Syed F, Khosla S 2005 Mechanisms of sex steroid effects on bone. Biochem Biophys Res Commun 328:688-696.
28. Amin S, Zhang Y, Felson DT, Sawin CT, Hannan MT, Wilson PW, Kiel DP 2006 Estradiol, testosterone, and the risk for hip fractures in elderly men from the Framingham Study. Am J Med 119:426-433.
29. Cummings SR, Browner WS, Bauer D, Stone K, Ensrud K, Jamal S, Ettinger B 1998 Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group. N Engl J Med 339:733-738.
30. Prestwood KM, Kenny AM, Kleppinger A, Kulldorff M 2003 UI-tralow-dose micronized 17beta-estradiol and bone density and bone metabolism in older women: A randomized controlled trial. JAMA 290:1042-1048.
31. Huang A, Ettinger B, Vittinghoff E, Ensrud KE, Johnson KC, Cummings SR 2007 Endogenous estrogen levels and the effects of ultra low-dose transdermal estradiol therapy on bone turnover and bone density in postmenopausal women. J Bone Miner Res 22:1791-1797.
32. Kohn FM 2006 Testosterone and body functions. Aging Male 9:183-188.
33. Ammann P, Rizzoli R, Bonjour JP, Bourrin S, Meyer JM, Vassalli P, Garcia I 1997 Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency. J Clin Invest 99:1699-1703.
34. Gao Y, Qian WP, Dark K, Toraldo G, Lin AS, Guldberg RE, Flavell RA, Weitzmann MN, Pacifici R 2004 Estrogen prevents bone loss through transforming growth factor beta signaling in T cells. Proc Natl Acad Sci USA 101:16618-16623.
35. Horwitz MCL 2002 IL-10, IL-4, the LIF/IL-6 family, and additional cytokines. In: Bilezikian JP, Raisz LG, Rodan GA (eds.) Principles of Bone Biology. Academic Press, San Diego, CA, USA, pp. 961-977.
36. Kawaguchi H, Pilbeam CC, Vargas SJ, Morse EE, Lorenzo JA, Raisz LG 1995 Ovariectomy enhances and estrogen replacement inhibits the activity of bone marrow factors that stimulate prostaglandin production in cultured mouse calvariae. J Clin Invest 96:539-548.
37. Pierroz DD, Bouxsein ML, Rizzoli R, Ferrari SL 2006 Combined treatment with a beta-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice. Bone 39:260-267.
38. Weitzmann MN, Cenci S, Rifas L, Haug J, Dipersio J, Pacifici R 2001 T cell activation induces human osteoclast formation via receptor activator of nuclear factor kappaB ligand-dependent and-independent mechanisms. J Bone Miner Res 16:328-337.
39. Charatcharoenwitthaya N, Khosla S, Atkinson EJ, McCready LK, Riggs BL 2007 Effect of blockade of TNF-alpha and interleukin-1 action on bone resorption in early postmenopausal women. J Bone Miner Res 22:724-729.
40. Jagger CJ, Lean JM, Davies JT, Chambers TJ 2005 Tumor necrosis factor-alpha mediates osteopenia caused by depletion of antioxidants. Endocrinology 146:113-118.
41. Lean JM. Jagger CJ, Kirstein B, Fuller K, Chambers TJ 2005 Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation. Endocrinology 146:728-735.
42. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, Staehelin HB, Bazemore MG, Zee RY, Wong JB 2004 Effect of vitamin D on falls: A meta-analysis. JAMA 291:1999-2006.
43. Wicherts IS, van Schoor NM, Boeke AJ, Visser M, Deeg DJ, Smit J, Knol DL, Lips P 2007 Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab 92:2058-2065.
44. Boonen S, Lips P, Bouillon R, Bischoff-Ferrari HA, Vandersch-ueren D, Haentjens P 2007 Need for additional calcium to reduce the risk of hip fracture with vitamin d supplementation: Evidence from a comparative metaanalysis of randomized controlled trials. J Clin Endocrinol Metab 92:1415-1423.
45. Eriksen EF, Hodgson SF, Eastell R, Cedel SL, O'Fallon WM, Riggs BL 1990 Cancellous bone remodeling in type I (postmenopausal) osteoporosis'. Quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels. J Bone Miner Res 5:311-319.
46. Parfitt AM, Villanueva AR, Foldes J, Rao DS 1995 Relations between histologic indices of bone formation: Implications for the pathogenesis of spinal osteoporosis. J Bone Miner Res 10:466-173.
47. Lips P, Courpron P, Meunier PJ 1978 Mean wall thickness of trabecular bone packets in the human iliac crest: Changes with age. Calcif Tissue Res 26:13-17.
48. Rosen CJ 2004 Insulin-like growth factor I and bone mineral density: Experience from animal models and human observational studies. Best Pract Res Clin Endocrinol Metab 18:423-135.
49. Iqbal J, Sun L, Kumar TR, Blair HC, Zaidi M 2006 Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation. Proc Natl Acad Sci USA 103:14925-14930.
50. Zhou FH, Foster BK, Zhou XF, Cowin AJ, Xian CJ 2006 TNF-alpha mediates p38 MAP kinase activation and negatively regulates bone formation at the injured growth plate in rats. J Bone Miner Res 21:1075-1088.
51. Bonewald L 2007 Osteocytes as dynamic, multifunctional cells. Ann NY Acad Sci 1116:281-290.
52. Jilka R, Weinstein RS, Parfitt AM, Manolagas SC 2007 Quantifying osteoblast and osteocyte aptoptosis: Challenges and rewards. J Bone Miner Res 22:1492-1501.
53. Armstrong VJ, Muzylak M, Sunters A, Zaman G, Saxon LK, Price JS, Lanyon LE 2007 Wnt/beta-catenin signaling is a component of osteoblastic bone cell early responses to load-bearing and requires estrogen receptor alpha. J Biol Chem 282:20715-20727.
54. Kapur S, Baylink DJ, Lau KH 2003 Fluid flow shear stress stimulates human osteoblast proliferation and differentiation through multiple interacting and competing signal transduction pathways. Bone 32:241-251.
55. Triplett JW, O'Riley R, Tekulve K, Norvell SM, Pavalko FM 2007 Mechanical loading by fluid shear stress enhances IGF-1 receptor signaling in osteoblasts in a PKCzeta-dependent manner. Mol Cell Biomech 4:13-25.
56. Wadhwa S, Godwin SL, Peterson DR, Epstein MA, Raisz LG, Pilbeam CC 2002 Fluid flow induction of cyclo-oxygenase 2 gene expression in osteoblasts is dependent on an extracellular signal-regulated kinase signaling pathway. J Bone Miner Res 17:266-274.
57. Tinetti ME, Gordon C, Sogolow E, Lapin P, Bradley EH 2006 Fall-risk evaluation and management: Challenges in adopting geriatric care practices. Gerontologist 46:717-725.
58. Lazarenko OP, Rzonca SO, Hogue WR, Swain FL, Suva LJ, Lecka-Czernik B 2007 Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone. Endocrinology 148:2669-2680.
59. Karsenty G 2006 Convergence between bone and energy homeostases: Leptin regulation of bone mass. Cell Metab 4:341-348.
60. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P, Karsenty G 2007 Endocrine regulation of energy metabolism by the skeleton. Cell 130:456-169.
61. Prisby RD, Ramsey MW, Behnke BJ, Dominguez JM II, Donato AJ, Allen MR, Delp MD 2007 Aging reduces skeletal blood flow, endothelium-dependent vasodilation, and NO bioavailability in rats. J Bone Miner Res 22:1280-1288.